<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02465164</url>
  </required_header>
  <id_info>
    <org_study_id>HFM 2900</org_study_id>
    <nct_id>NCT02465164</nct_id>
  </id_info>
  <brief_title>Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henry Ford Health System</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare if using a Cook Cervical Ripening Balloon in&#xD;
      conjunction with low dose oxytocin is more effective at shortening labor induction times than&#xD;
      the Cook Cervical Ripening Balloon alone. After obtaining consent, patients will be randomly&#xD;
      divided into a Balloon with oxytocin or Balloon only group. The Balloon will be placed by&#xD;
      either Resident or Attending Physicians and left in place for 12 hours (protocol) in both&#xD;
      groups or until it falls out. After either 12 hours or the Balloon falls out, oxytocin will&#xD;
      be used for the remainder of the induction per current hospital protocol. Time to delivery,&#xD;
      mode of delivery, average number of hours Balloon remained in place, non-reassuring fetal&#xD;
      heart tracings, adverse outcomes (ie fetal malpresentation, postpartum hemorrhage) will be&#xD;
      recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to delivery</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cervical Ripening</condition>
  <arm_group>
    <arm_group_label>Cook catheter</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cook catheter plus low dose oxytocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Test group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cook catheter</intervention_name>
    <arm_group_label>Cook catheter</arm_group_label>
    <arm_group_label>Cook catheter plus low dose oxytocin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <arm_group_label>Cook catheter plus low dose oxytocin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. singleton pregnancy&#xD;
&#xD;
          2. reassuring fetal status at time of presentation&#xD;
&#xD;
          3. Bishop Score &lt;6&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Closed cervix&#xD;
&#xD;
          2. Breech presentation&#xD;
&#xD;
          3. Multiple gestations&#xD;
&#xD;
          4. Recent vaginal bleeding&#xD;
&#xD;
          5. Placenta previa&#xD;
&#xD;
          6. non reassuring fetal status&#xD;
&#xD;
          7. Active genital herpes infection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henry Ford Health System</investigator_affiliation>
    <investigator_full_name>Justin Bruner</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

